Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? Blood 2020 Jul 02;136(1):137-139

Date

05/28/2020

Pubmed ID

32457999

Pubmed Central ID

PMC7332891

DOI

10.1182/blood.2020006216

Scopus ID

2-s2.0-85087529450 (requires institutional sign-in at Scopus site)   53 Citations

Author List

Frigault MJ, Nikiforow S, Mansour MK, Hu ZH, Horowitz MM, Riches ML, Hematti P, Turtle CJ, Zhang MJ, Perales MA, Pasquini MC

Authors

Peiman Hematti MD Professor in the Medicine department at Medical College of Wisconsin
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin
Mei-Jie Zhang PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Betacoronavirus
Coronavirus Infections
Female
Hematologic Neoplasms
Humans
Immunotherapy, Adoptive
Male
Middle Aged
Pandemics
Pneumonia, Viral
Risk Factors